Serum prolactin response to a D2 antagonist in narcoleptic and control canines.
Nishino
S
S
Arrigoni
J
J
Sharp
L H
LH
Shelton
J D
JD
Dement
W C
WC
Mignot
E
E
D000818:Animals; D004283:Dog Diseases / Q000097:blood / Q000188:drug therapy*; D004285:Dogs; D065127:Dopamine D2 Receptor Antagonists; D004305:Dose-Response Relationship, Drug; D005260:Female; D007262:Infusions, Intravenous; D008297:Male; D009290:Narcolepsy / Q000097:blood / Q000188:drug therapy / Q000662:veterinary*; D011388:Prolactin / Q000097:blood*; D020891:Raclopride; D012457:Salicylamides / Q000627:therapeutic use*
D065127:Dopamine D2 Receptor Antagonists; D012457:Salicylamides; D020891:Raclopride; D011388:Prolactin